General
Preferred name
PIPERAQUINE
Synonyms
Piperaquine tetraphosphate tetrahydrate ()
Piperaquine (phosphate) ()
Piperaquine (tetraphosphate tetrahydrate) ()
PIPERAQUINE PHOSPHATE ()
PIPERAQUINE TETRAPHOSPHATE ()
Piperaquinoline ()
Piperaquine phosphate component of eurartesim piperaquine tetraphosphate ()
P&D ID
PD071703
CAS
915967-82-7
4085-31-8
85547-56-4
Tags
available
drug
drug candidate
Approved by
EMA
First approval
2011
Drug indication
Plasmodium vivax malaria
Malaria
Drug Status
approved
experimental
investigational
Max Phase
2.0
1.0
3.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION

Piperaquine is listed in the WHO 20th Essential Medicines List (2017) as an antimalarial for curative treatment in combination with . This is one of the ACT recommended in the WHO Guidelines for the treatment of malaria .

Potential Target/Mechanism Of Action:
DESCRIPTION Piperaquine is a 4-aminoquinoline antimalarial compound.

The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. (GtoPdb)
DESCRIPTION Piperaquine tetraphosphate tetrahydrate is a potent anti-parasites agent. (TargetMol Bioactive Compound Library)
Cell lines
0
Organisms
3
Compound Sets
14
Cayman Chemical Bioactives
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
60
Properties
(calculated by RDKit )
Molecular Weight
534.21
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
0
Rotatable Bonds
6
Ring Count
6
Aromatic Ring Count
4
cLogP
5.42
TPSA
38.74
Fraction CSP3
0.38
Chiral centers
0.0
Largest ring
6.0
QED
0.33
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Parasite
Indication
malaria
MOA
antimalarial agent
Pathway
Microbiology/virology
Anti-infection
Source data